Search
Biomx Inc
PHGEAdd to Watchlist
0.319USD
+0.007+2.13%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
508.39KMarket Cap
LossP/E TTM
More Details of Biomx Inc Company
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Biomx Inc Info
Ticker SymbolPHGE
Company nameBiomx Inc
IPO dateDec 18, 2018
CEOSolomon (Jonathan Eitan)
Number of employees52
Security typeOrdinary Share
Fiscal year-endDec 18
Address22 Einstein St.
CityNESS-ZIONA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryIsrael
Postal code7414003
Phone972723942377
Websitehttps://www.biomx.com/
Ticker SymbolPHGE
IPO dateDec 18, 2018
CEOSolomon (Jonathan Eitan)
Company Executives of Biomx Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
9.46K
+0.01%
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
5.86K
+0.02%
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
3.63K
+0.03%
Dr. Russell G. Greig, Ph.D.
Dr. Russell G. Greig, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Mr. Eddie Williams
Mr. Eddie Williams
Independent Director
Independent Director
--
--
Dr. Jesse Goodman, M.D.
Dr. Jesse Goodman, M.D.
Independent Director
Independent Director
--
--
Mr. Jonathan S. Leff
Mr. Jonathan S. Leff
Independent Director
Independent Director
--
--
Mr. Gregory Merril
Mr. Gregory Merril
Independent Director
Independent Director
--
--
Ms. Susan Blum, CPA
Ms. Susan Blum, CPA
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
9.46K
+0.01%
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
5.86K
+0.02%
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
3.63K
+0.03%
Dr. Russell G. Greig, Ph.D.
Dr. Russell G. Greig, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Mr. Eddie Williams
Mr. Eddie Williams
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Biomx Inc?
The top five shareholders of Biomx Inc are: Mr. Jonathan Eitan Solomon
How many institutions hold shares of Biomx Inc (PHGE)?
As of 2026Q1, 36 institutions hold shares of Biomx Inc, with a combined market value of approximately 319.22K, accounting for 6.63% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -512775.00.